Mentalizing in adults with narcolepsy type 1
Part of Brain & nervous system clinical trials.
This study looks at how people with type 1 narcolepsy understand their own and others' thoughts and feelings (called mentalizing). It compares them to people with treated sleep apnea to see if there are differences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 narcolepsy and had a sleep study, OR you have treated sleep apnea with no leftover breathing problems.
- You are 18 years or older.
- You are covered by French social security (health insurance).
- You do not have a history of autism, chronic psychotic disorder, or bipolar disorder.
- You have no cognitive problems from a neurological condition, and you can understand French well enough to answer questionnaires.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares gut bacteria and substances from the gut in people with type 1 narcolepsy versus those without. It aims to understand how gut health might be linked to this sleep disorder.
This study looks at whether people with narcolepsy or idiopathic hypersomnia have different patterns of daydreaming and mind-wandering compared to others with sleepiness but no clear diagnosis. It helps understand how certain brain states during sleep might affect waking thoughts.
This study looks at people with narcolepsy type 1 or type 2 in Spain to learn more about these conditions. If you or your child has a confirmed diagnosis, you may be able to take part.
This trial tests a non-invasive brain stimulation method called temporal interference to target the hypothalamus. It aims to help reduce excessive daytime sleepiness in people with narcolepsy type 1.
This study tests a new behavioral treatment to reduce nightmares in adults with narcolepsy. It aims to help you sleep better and feel more rested.
This study tests a new medication called TAK-360 to help adults with narcolepsy type 1 (a condition that causes extreme daytime sleepiness and sudden muscle weakness called cataplexy) feel more alert during the day. The goal is to see if this treatment is safe and effective for managing narcolepsy symptoms.
Hear when a new Narcolepsy Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.